Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Rakovitch

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 25, 2021
Managing the Minefields in Optimal TreatmentDanielle Rodin, Eileen Rakovitch
The Lancet. Oncology|October 20, 2018
The effect of postmastectomy radiotherapy on patient-reported outcomesEileen Rakovitch, Lawrence Paszat
Cureus|May 24, 2017
Improving Therapeutic Ratios with the Oncotype DX® Ductal Carcinoma In Situ (DCIS) ScoreNafisha Lalani, Eileen Rakovitch
Breast Cancer Research and Treatment|May 10, 2020
The impact of ductal carcinoma in situ on health services utilizationLawrence Paszat, Rinku Sutradhar, Eileen Rakovitch
The American Journal of Pathology|January 4, 2019
Molecular Evaluation of Breast Ductal Carcinoma in Situ with Oncotype DX DCISSharon Nofech-Mozes, Wedad Hanna, Eileen Rakovitch
JAMA Oncology|March 12, 2016
Treatment and Long-term Risks for Patients With a Diagnosis of Ductal Carcinoma In SituAbram Recht, Eileen Rakovitch, Lawrence J Solin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Is breast conservation therapy superior to mastectomy for women with triple-negative breast cancers?Jean-Philippe Pignol, Eileen Rakovitch, Ivo A Olivotto
Advances in Anatomic Pathology|October 8, 2005
Prognostic and predictive molecular markers in DCIS: a reviewSharon Nofech-Mozes, Jacqueline Spayne, Eileen Rakovitch, et al.
Clinical Chemistry|November 23, 2013
Ductal carcinoma in situ of the breast: can biomarkers improve current management?John M S Bartlett, Sharon Nofech-Moses, Eileen Rakovitch
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Clinical significance of atomic inner shell ionization (ISI) and Auger cascade for radiosensitization using IUdR, BUdR, platinum salts, or gadolinium porphyrin compoundsJean-Philippe Pignol, Eileen Rakovitch, David Beachey, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|June 25, 2021
Managing the Minefields in Optimal TreatmentDanielle Rodin, Eileen Rakovitch
The Lancet. Oncology|October 20, 2018
The effect of postmastectomy radiotherapy on patient-reported outcomesEileen Rakovitch, Lawrence Paszat
Cureus|May 24, 2017
Improving Therapeutic Ratios with the Oncotype DX® Ductal Carcinoma In Situ (DCIS) ScoreNafisha Lalani, Eileen Rakovitch
Breast Cancer Research and Treatment|May 10, 2020
The impact of ductal carcinoma in situ on health services utilizationLawrence Paszat, Rinku Sutradhar, Eileen Rakovitch
The American Journal of Pathology|January 4, 2019
Molecular Evaluation of Breast Ductal Carcinoma in Situ with Oncotype DX DCISSharon Nofech-Mozes, Wedad Hanna, Eileen Rakovitch
JAMA Oncology|March 12, 2016
Treatment and Long-term Risks for Patients With a Diagnosis of Ductal Carcinoma In SituAbram Recht, Eileen Rakovitch, Lawrence J Solin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Is breast conservation therapy superior to mastectomy for women with triple-negative breast cancers?Jean-Philippe Pignol, Eileen Rakovitch, Ivo A Olivotto
Advances in Anatomic Pathology|October 8, 2005
Prognostic and predictive molecular markers in DCIS: a reviewSharon Nofech-Mozes, Jacqueline Spayne, Eileen Rakovitch, et al.
Clinical Chemistry|November 23, 2013
Ductal carcinoma in situ of the breast: can biomarkers improve current management?John M S Bartlett, Sharon Nofech-Moses, Eileen Rakovitch
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Clinical significance of atomic inner shell ionization (ISI) and Auger cascade for radiosensitization using IUdR, BUdR, platinum salts, or gadolinium porphyrin compoundsJean-Philippe Pignol, Eileen Rakovitch, David Beachey, et al.
Pageof 10